Welcome to Dr. Rousho Radio, discussing the cutting edge in health, nutrition, and functional medicine.

To make sure you're up to date on this and other important topics, visit Dr. Roushho.com and sign up to receive weekly updates.

That's d r-r-r-r-us-c-io.com.

The following discussion is for educational purposes only and is not intended to diagnose or treat

any disease.

Please do not apply any of this information without first speaking with your doctor.

Now let's head to the show.

Hi, everyone. Welcome back to another episode of Dr. Racial Radio.

Today, I speak with Lihi Seagal, who is the CEO of Day 2.

Now, remember back, we interviewed a researcher who published a paper in cell about this pioneering technology

where we can take a stool sample look at one's microbiota and use that to accurately predict what

foods one may do well from a blood sugar perspective and ones that may really spike your blood sugar.

Now, day two has taken that research and they've done something that many microbata labs have not done.

They have actually validated that their external application of that technology can work in a clinical setting with a kind of case

control series of studies where they look at the effect of a healthy reference diet compared

to diets guided by their microbiota testing and have consistently shown in these two initial pilot studies and

one follow-up study that is about to close and will soon publish that yes you can actually

use this data to outperform a reference diet and this is very exciting because they are showing improvements in blood

sugar and also improvements in weight and energy. And they have some data they're collecting now

suggesting that they may even see improvements in IBS. So why this is exciting is because many,

unfortunately, microbiota tests make claims that

they can't support and they haven't gone through this validation. Why that matters to you as a consumer

...